Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Catalyst Pharmaceuticals, Inc. (CPRX) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for January 10th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 10th:
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.9% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote
Immunocore’s shares gained 52% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
Immunocore Holdings PLC Sponsored ADR Price
Immunocore Holdings PLC Sponsored ADR price | Immunocore Holdings PLC Sponsored ADR Quote
Catalyst Pharmaceuticals, Inc. (CPRX - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25.7% over the last 60 days.
Catalyst Pharmaceuticals, Inc. Price and Consensus
Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote
Catalyst’s shares gained 17.4% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
Catalyst Pharmaceuticals, Inc. Price
Catalyst Pharmaceuticals, Inc. price | Catalyst Pharmaceuticals, Inc. Quote
AmpriusTechnologies, Inc. (AMPX - Free Report) : This ultra-high energy density lithium-ion batteries company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.5% over the last 60 days.
Amprius Technologies, Inc. Price and Consensus
Amprius Technologies, Inc. price-consensus-chart | Amprius Technologies, Inc. Quote
Amprius’s shares gained 11.5% over the last three months compared with the S&P 500’s advance of 8.4%. The company possesses a Momentum Score of A.
Amprius Technologies, Inc. Price
Amprius Technologies, Inc. price | Amprius Technologies, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.